Back to VG Vanguard Global Advisers, LLC
CTSO
2 quarters
Position history for VGVanguard Global Advisers, LLC's holdings in Cytosorbents Corporation
Yes. Vanguard Global Advisers holds 13,865 shares of CTSO (Cytosorbents), worth $5,186, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Vanguard Global Advisers has held CTSO in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$5,186
Current Shares
13,865
Total Value Change
-$2,662
Total Shares Change
0
Quarter-by-Quarter History